Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

OBJECTIVE: To assess the uptake of second line antihyperglycaemic drugs among patients with type 2 diabetes mellitus who are receiving metformin. DESIGN: Federated pharmacoepidemiological evaluation in LEGEND-T2DM. SETTING: 10 US and seven non-US electronic health record and administrative claims da...

Descripción completa

Detalles Bibliográficos
Autores principales: Khera, Rohan, Dhingra, Lovedeep Singh, Aminorroaya, Arya, Li, Kelly, Zhou, Jin J, Arshad, Faaizah, Blacketer, Clair, Bowring, Mary G, Bu, Fan, Cook, Michael, Dorr, David A, Duarte-Salles, Talita, DuVall, Scott L, Falconer, Thomas, French, Tina E, Hanchrow, Elizabeth E, Horban, Scott, Lau, Wallis CY, Li, Jing, Liu, Yuntian, Lu, Yuan, Man, Kenneth KC, Matheny, Michael E, Mathioudakis, Nestoras, McLemore, Michael F, Minty, Evan, Morales, Daniel R, Nagy, Paul, Nishimura, Akihiko, Ostropolets, Anna, Pistillo, Andrea, Posada, Jose D, Pratt, Nicole, Reyes, Carlen, Ross, Joseph S, Seager, Sarah, Shah, Nigam, Simon, Katherine, Wan, Eric YF, Yang, Jianxiao, Yin, Can, You, Seng Chan, Schuemie, Martijn J, Ryan, Patrick B, Hripcsak, George, Krumholz, Harlan, Suchard, Marc A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565313/
https://www.ncbi.nlm.nih.gov/pubmed/37829182
http://dx.doi.org/10.1136/bmjmed-2023-000651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565313/
https://www.ncbi.nlm.nih.gov/pubmed/37829182
http://dx.doi.org/10.1136/bmjmed-2023-000651

Ejemplares similares